Navigation Links
Roche's Sequence Capture Technology Used to Identify SMPX Mutations Underlying Human Hereditary Hearing Loss
Date:1/12/2012

MADISON, Wisconsin, January 12, 2012 /PRNewswire/ --

Hereditary hearing loss is the most common sensory disorder in humans. A German research team led by Ingo Kurth from the Institute of Human Genetics at the University Hospital Jena, Germany, used a number of different methods, including Roche's NimbleGen Custom Sequence Capture 385K array to identify the gene mutated in the disease locus of the X-chromosome of a Spanish family with hereditary hearing loss (1).

Targeted enrichment was performed by the German Service Provider ATLAS Biolabs GmbH. In particular, the DNA of two affected males was subjected to target enrichment. Subsequent sequencing analysis at the Cologne Center for Genomics (CCG) resulted in the identification of a total of 3858 and 3443 X-chromosomal variants for each of these two individuals. Furthermore, a nonsense mutation in the small muscle protein, X-linked (SMPX) of the affected individuals had been detected. Nonsense mutations are significant, because they are point mutations in a sequence of DNA that cause a premature stop codon, or a nonsense codon in the transcribed mRNA, resulting in a truncated, incomplete, and usually nonfunctional protein. Based on their findings, the authors propose that long-term maintenance of mechanically stressed inner ear cells critically depends on SMPX function.

The NimbleGen Sequence Capture technology is a sophisticated process for the parallel enrichment of selected genomic regions from complex human genomic DNA. Sequence Capture allows enrichment of target regions in a single experiment, replacing the need to perform numerous PCR reactions. The efficiencies of parallel enrichment are an ideal complement for cost-effective, high throughput next-generation sequencing.

  1. Huebner et al., American Journal of Human Genetics, Vol. 88: 621-627, May 13, 2011

About Roche

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche's personalised healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2010, Roche had over 80,000 employees worldwide and invested over 9 billion Swiss francs in R&D. The Group posted sales of 47.5 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information: http://www.roche.com.

For life science research only.  Not for use in diagnostic procedures.

NIMBLEGEN and SEQCAP are trademarks of Roche.


Other brands or product names are trademarks of their respective holders.

Roche Diagnostics
Dr. Burkhard Ziebolz
Tel.: +49-(0)8856-604830
E-Mail: burkhard.ziebolz@roche.com

Roche NimbleGen
Kary Staples
Tel.: +1-608-218-7623
E-Mail: kary.staples@roche.com



'/>"/>
SOURCE Roche Diagnostics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
2. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
3. Rochester Medical Announces Fourth Quarter 2009 Earnings Conference Call Thursday, November 5th 2009
4. Rochester Medical Reports Fourth Quarter and Annual Results and Announces Final Medicare Approval for Reimbursement for the FEMSOFT(R) Insert
5. Rochester Medical Announces First Quarter 2010 Earnings Conference Call Tuesday, January 26, 2010
6. Rochester Medical Corporation Honored by Premier Healthcare Alliance for Exceptional Supplier Performance
7. AstraZeneca Joins Rochester Initiative to Further Cardiac Safety
8. Rochester Medical Announces Fourth Quarter 2010 Earnings Conference Call Thursday, November 4, 2010
9. Rochester Medical Reports Fourth Quarter and Year-End Results
10. Rochester Medical Corporation Announces Agreement to Acquire Laprolan B.V.
11. Rochester Medical Announces First Quarter 2011 Earnings Conference Call Tuesday, January 25, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... SEATTLE , Aug. 18, 2017  Nortis today ... provide funding for the third year of a Small ... the National Institute of Neurological Disorders and Stroke (NINDS).?  ... Nortis ... ...
(Date:8/17/2017)... -- MJAC2017 , the premier cannabis event devoted to ... its leading lineup. MJAC2017 is proud ... specializing in the development of pharmaceutical and consumer products, will ... The Green Organic Dutchman are gold sponsors for the event, ... ...
(Date:8/17/2017)... CAESAREA, Israel , August 17, 2017 /PRNewswire/ ... digital health Company with mobile health and big ... securities purchase agreements with domestic and non-U.S. investors ... common stock and shares of the Company,s newly ... private placement offerings. The Company expects to conduct ...
Breaking Medicine Technology:
(Date:8/22/2017)... ... 22, 2017 , ... John Stewart joins Privis Health as ... t4 Leadership Development & Consulting. He has spent his career focusing on four ... development, servant leadership, data driven process improvement, and supportive technology. These key elements ...
(Date:8/21/2017)... ... August 22, 2017 , ... PracticeMatch, a company that provides ... employers connect with physicians and advanced practitioners like nurse practitioners and ... in August through November of this year. The online career fairs will allow job ...
(Date:8/21/2017)... ... August 21, 2017 , ... FCPX LUT Monochromatic Volume 2 is an ... easily add washed color grades to footage. A LUT is a Lookup Table that ... to the corresponding color indicated by the table. This pack comes with 60 different ...
(Date:8/21/2017)... ... 21, 2017 , ... Duncan Insurance Agency debuts the latest ... Michigan. The new initiative fundraises for the Kalamazoo Humane Society (KHS), which has ... protection and welfare by addressing the root causes of pet overpopulation. As well ...
(Date:8/21/2017)... San Diego, CA (PRWEB) , ... August 21, 2017 , ... ... Membership ( MAM ) health care reform plan, has announced his candidacy for the ... the American Dream and shared in America’s Promise. Coming to this country at age ...
Breaking Medicine News(10 mins):